Red Cell Filter market is expected to mark significant growth over forecasted period owing to increasing consumers spending on Leucodepletion,
Leukoreduction applications and technological advancement.
By product, the apheresis devices segment is expected to account for the largest share of the leukapheresis devices market in 2018 On the basis of type, the Leukapheresis Devices Market is segmented into apheresis devices, leukapheresis columns & cell separators, and
leukoreduction filters.
phagocytophilum is found predominantly within granulocytes,
leukoreduction lowers the risk of transfusion-transmitted anaplasmosis (TTA) by reducing the level of the organism by 300-fold (5).
Theoretically,
leukoreduction (also known as leukodepletion or leukofiltration) could remove a sufficient number of white blood cells to limit TAGVHD; however, there have been 23 reported cases of TA-GVHD after transfusion of leukoreduced red blood cells in the literature, (39) indicating
leukoreduction alone is not adequate to prevent TA-GVHD.
The risk of febrile reaction is reduced to 0.2 percent when patients receive prestorage leukoreduced blood products but increased to 2 percent for poststorage
leukoreduction [18].
Whereas other studies have fabricated microfluidic devices as effective high-throughput
leukoreduction filters [21], we incorporate these ceramic HFs into 3D porous scaffolds serving as a perfusion platform with continuous cell filtration harvest.
(8) in the Netherlands in this context identified non-leuco-reduction as being associated with increased incidence of multiorgan dysfunction, infection and length of hospital stay (8) resulting alongside other studies in the immediate initiation of the EU directive for pre-storage
leukoreduction to be required for all banked blood.
Griffin et al., "Age of transfused blood: an independent predictor of mortality despite universal
leukoreduction," The Journal of Trauma, vol.
The association of red cell transfusions with post-operative infections has been shown in randomized clinical trials to be partially mitigated by
leukoreduction. (3,4) Restricting the transfusion of red cells to much lower levels of hemoglobin than previously thought ideal (< 7g/dl or hematocrit of < 21) also reduces the number of patients who develop HAIs.
Leukapheresis rapidly yields
leukoreduction and is the initial treatment of hyperleukocytosis with symptoms.
